-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Large Growth in Short Interest
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Large Growth in Short Interest
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 11,800 shares, a growth of 20.4% from the November 15th total of 9,800 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is presently 1.3 days. Currently, 0.5% of the company's stock are sold short.
Pro-Dex Stock Performance
Pro-Dex stock traded up $0.41 during midday trading on Friday, reaching $17.80. 887 shares of the company's stock were exchanged, compared to its average volume of 7,985. Pro-Dex has a 52 week low of $12.40 and a 52 week high of $26.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. The firm has a market cap of $63.72 million, a price-to-earnings ratio of 17.12 and a beta of 0.91. The stock's 50-day simple moving average is $18.07 and its 200 day simple moving average is $17.27.
Get Pro-Dex alerts:Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on Pro-Dex in a report on Thursday. They set a "buy" rating for the company.
Hedge Funds Weigh In On Pro-Dex
Hedge funds and other institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. boosted its holdings in shares of Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock worth $345,000 after acquiring an additional 7,762 shares during the period. LSV Asset Management raised its position in shares of Pro-Dex by 13.9% in the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after buying an additional 4,346 shares in the last quarter. State Street Corp raised its position in shares of Pro-Dex by 5.8% in the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after buying an additional 650 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Pro-Dex in the second quarter valued at approximately $168,000. Finally, Tower Research Capital LLC TRC raised its position in shares of Pro-Dex by 345.6% in the third quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 2,084 shares in the last quarter. Institutional investors own 13.69% of the company's stock.About Pro-Dex
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Read More
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 11,800 shares, a growth of 20.4% from the November 15th total of 9,800 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is presently 1.3 days. Currently, 0.5% of the company's stock are sold short.
Pro-Dex，Inc.(納斯達克代碼：PDEX-GET Rating)11月份在空頭股數上實現了大幅增長。截至11月30日，空頭股數共有11,800股，較11月15日的9,800股增長20.4%。以9,000股的平均成交量計算，目前短息比率為1.3天。目前，該公司0.5%的股票被賣空。
Pro-Dex Stock Performance
Pro-Dex股票表現
Pro-Dex stock traded up $0.41 during midday trading on Friday, reaching $17.80. 887 shares of the company's stock were exchanged, compared to its average volume of 7,985. Pro-Dex has a 52 week low of $12.40 and a 52 week high of $26.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. The firm has a market cap of $63.72 million, a price-to-earnings ratio of 17.12 and a beta of 0.91. The stock's 50-day simple moving average is $18.07 and its 200 day simple moving average is $17.27.
在週五午盤交易中，支持Dex的股票上漲了0.41美元，達到17.80美元。該公司股票成交量為887股，而其平均成交量為7985股。Pro-Dex的52周低點為12.40美元，52周高位為26.50美元。該公司的負債權益比率為0.41，速動比率為1.39，流動比率為2.73。該公司市值為6,372萬美元，本益比為17.12倍，貝塔係數為0.91。該股的50日簡單移動均線切入位為18.07美元，200日簡單移動均線切入位為17.27美元。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Separately, StockNews.com assumed coverage on Pro-Dex in a report on Thursday. They set a "buy" rating for the company.
另外，StockNews.com在週四的一份報告中對Pro-Dex進行了報道。他們為該公司設定了“買入”評級。
Hedge Funds Weigh In On Pro-Dex
對沖基金對Pro-Dex的看法
About Pro-Dex
關於Pro-Dex
(Get Rating)
(獲取評級)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex公司為世界各地的醫療器械原始設備製造商設計、開發、製造和銷售動力手術器械。該公司提供可高壓滅菌、電池供電和電動的多功能外科驅動程式和剃鬚刀，主要用於整形外科、胸部和顱頜面部市場。
Read More
閱讀更多內容
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Which Two Bluechip Tech Companies Have Raised Their Guidance?
- Should You Worry About Elon Musk Selling His Tesla Shares?
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- 免費獲取StockNews.com Pro-Dex上的研究報告(PDEX)
- 哪兩家藍籌科技公司提高了他們的指引？
- 你應該擔心埃隆·馬斯克出售他持有的特斯拉股票嗎？
- 拖拉機庫存能否突破杯柄收購點？
- 現在不是購買Lennar的時候，但時機即將到來
- 馬倫汽車公司改變遊戲規則的消息
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pro-Dex Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pro-Dex和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧